{{Rsnum
|rsid=10280101
|Gene=ABCB1
|Chromosome=7
|position=87524269
|Orientation=plus
|GMAF=0.1299
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(A;A)
|geno2=(A;C)
|geno3=(C;C)
|Gene_s=ABCB1
}}{{ population diversity
| geno1=(A;A)
| geno2=(A;C)
| geno3=(C;C)
| CEU | 71.7 | 27.4 | 0.9
| HCB | 90.5 | 9.5 | 0.0
| JPT | 82.3 | 15.9 | 1.8
| YRI | 56.5 | 36.1 | 7.5
| ASW | 66.7 | 29.8 | 3.5
| CHB | 90.5 | 9.5 | 0.0
| CHD | 93.6 | 6.4 | 0.0
| GIH | 65.3 | 32.7 | 2.0
| LWK | 63.6 | 29.1 | 7.3
| MEX | 79.3 | 20.7 | 0.0
| MKK | 61.5 | 32.1 | 6.4
| TSI | 71.3 | 27.7 | 1.0
| HapMapRevision=28
}}{{PharmGKB
|RSID=rs10280101
|Name_s=
|Gene_s=ABCB1
|Feature=
|Evidence=PubMed ID:18215618
|Annotation=This variant is associated with differences in clinical efficacy of antidepressants, most likely by influencing their access to the brain.
|Drugs=amitriptyline; citalopram; paroxetine; venlafaxine
|Drug Classes=
|Diseases=Depression
|Curation Level=Curated
|PharmGKB Accession ID=PA161615694
}}

{{PMID Auto
|PMID=18382661
|Title=Pharmacokinetic genes do not influence response or tolerance to citalopram in the STAR*D sample.
|OA=1
}}

{{GET Evidence
|impact=pharmacogenetic
|qualified_impact=Insufficiently evaluated pharmacogenetic
|inheritance=unknown
|quality_scores=Array
|dbsnp_id=rs10280101
|overall_frequency_n=19
|overall_frequency_d=128
|overall_frequency=0.148438
|n_genomes=14
|n_genomes_annotated=0
|n_haplomes=17
|n_articles=1
|n_articles_annotated=0
|in_pharmgkb=Y
|autoscore=2
|webscore=N
|n_web_uneval=10
}}

{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}
{{on chip | Affy GenomeWide 6}}
{{on chip | FTDNA2}}
{{on chip | HumanOmni1Quad}}
{{on chip | Illumina Human 1M}}